期刊文献+

大同市成年女性HPV感染及基因型分析 被引量:22

Prevalence and type distribution of human papillomavirus infection in women of Datong,China
原文传递
导出
摘要 目的调查山西省大同市成年女性人乳头瘤病毒(HPV)感染及亚型分布情况。方法采用PCR以及线形杂交法(LA)对931名女性宫颈脱落细胞标本进行HPV基因检测和基因分型。结果正常组、低度上皮内损伤(LSIL)组、高度上皮内损伤(HSIL)组及鳞状细胞癌(SCC)组HPV感染率分别为18.6%,60.2%,69.2%和84.6%;高危型HPV感染率明显高于低危型(P〈0.001);感染高峰为18-25岁年龄组;总体人群中HPV-16、HPV-58、HPV-18、HPV-52以及HPV-33的感染率最高,依次为15.8%,4.7%,3.8%,3.0%和1.8%,而SCC组中,HPV-16、HPV-18、HPV-58、HPV-52以及HPV-33的感染率最高,分别为61.5%,11.5%,7.7%,3.8%,3.8%。结论大同市女性人群HPV感染状况及HPV基因型分布与国内其他地区存在明显差异。 Objective To survey the prevalence and type distribution of human papillomavirus (HPV) infection in women of Datong. Methods A total of 931 cervical specimens from women attending routine Pap smear cytology screening were subjected to FIPV detection and genotyping with PCR-LA assay. Results The overall HPV prevalence was 18.6% in normal specimens,60. 2% in specimens with light epithelial internal lesion,69. 2% in severe epithelial internal lesion, and 84. 6% in specimens with squamous cell carcinoma(SCC) ,respectively. High risk HPV infections were more prevalent than low risk HPV types ( P 〈 0.05 ). The peak of high risk HPV infection was found in subjects of 18-25 years old. The prevalence of HPV was 15.8 % ,4. 7 % ,3.8 %, and 1.8 % for HPV - 16, - 58,18, and - 52 in all participants, respectively. But In SCC,HPV-16(61.5% ) ,-18(11.5% ) -58(7.7% ) ,-52 (3.8%) and -33(3.8% ) were prevalent types. Conelusion The study demonstrated the geographic variability of oncogenic HPV distribution in Datong, China.
出处 《中国公共卫生》 CAS CSCD 北大核心 2009年第10期1159-1160,共2页 Chinese Journal of Public Health
基金 山西省青年科技研究基金(2007021051)
关键词 人乳头瘤病毒(HPV) 感染 基因型 human papillomavirus(HPV) infection genotype
  • 相关文献

参考文献5

二级参考文献42

  • 1张文淼,帅茨霞,郑飞云,黄引平,王群姬,朱华,何秋香.脆性组氨酸三联体基因在宫颈癌前病变和宫颈癌中的表达及其与p53和HPV16/18的关系[J].中华肿瘤杂志,2006,28(6):452-455. 被引量:26
  • 2常志伟,王立东,王宁博,王苒,江亚南,杜芳,齐义军,郭涛,孙哲,李吉林,常扶保,常志军,郭海云,未庆丽,范宗民,高珊珊,何欣,郭花芹.家族史阳性和阴性食管癌患者癌组织中FHIT和BRCA2及MLH1的表达变化[J].中华肿瘤防治杂志,2006,13(18):1371-1374. 被引量:10
  • 3Parkin DM, Pasini P, Ferlay J. Estimate of the worldwide incidence of 25 major cancers in 1990 [J]. Int J Cancer 1999; 54: 827-41.
  • 4Parkin DM, Bray F, Ferlay J, et al. Estimate of the world cancer burden: globocan 2000 [J]. Int J Cancer 2001 ; 94:153 - 156.
  • 5Jacobs MV, Walsh MY, Thomton CM, et al. Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intermethod comparison [J]. Clin Pathol 1999; 52: 498- 503.
  • 6Keating JT, Ince T, Crum CP. Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis [ J ]. Adv Anat Pathol.2001 Mar; 8 (2) : 83 - 92.
  • 7Volgareva GM, Zavalishina LE, Andreeva YY, et al. Protein p16INK4a as a marker of dysplastic and neoplastic alterations in cervical epithelial cells [J]. BMC Cancer. 2004 Aug 31; 4 (1): 58.
  • 8Quade BJ, Park JJ, Crum CP, et al. In vivo cyclin E expression as a marker for early cervical neoplasia [J]. Mod Pathol. 1998 Dec; 11(12): 1238-46.
  • 9Riethdorf L, Riethdrof S, Lee KR, et al. Human papillomaviruses,expression of p16, and early endocervical glandular neoplasia [J].Hum Pathol. 2002 Sep; 33 (9): 899-904.
  • 10Agoff SN, Lin P, Morihara J, et al. p16 (INK4a) expreesion correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types [J]. Mod Pathol. 2003 Jul;16 (7) : 665- 73.

共引文献60

同被引文献163

引证文献22

二级引证文献138

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部